Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

During 1978 little cryoprecipitate was used and the NHS and commercial factor VIII levels broadly remained similar to the year before at the Birmingham Haemophilia Centre

Published on: 27 September, 2024

In 1979 almost no cryoprecipitate was used and the amount of commercial concentrate was well over double the amount of NHS concentrate at the Birmingham Haemophlia Centre

Published on: 27 September, 2024

Professor Frank Hill at the time believed hepatitis was a minor self limiting condition with no serious long-term consequences

Published on: 27 September, 2024

Dr Hill and Dr Stuart were concerned about the risks of hepatitis and were of the view that it would have been advantageous to reserve NHS Factor 8 for children.

Published on: 27 September, 2024

By 1975 Dr Colvin was aware that there was at least a possibility of chronic liver disease in haemophilia

Published on: 27 September, 2024

Dr Hill reported to the December 1979 meeting of the West Midlands Working Party that the Hepatitis Working Party had reported that Commercial Factor VIII carried the risk of hepatitis, and he was concerned that some children at the Childrens Hospital had become hepatitis carriers

Published on: 27 September, 2024

In 1979, Dr Kernoff held that while cryoprecipitate was cheap to produce it had serious clinical disadvantages and that the NHS's shortfall had to be addressed through buying commercial concentrate.

Published on: 27 September, 2024

In 1979, Dr Kernoff described NANBH was a serious disease with long-term consequences.

Published on: 27 September, 2024

In 1979 Dr Kernoff and Dr Colvin authorised guidelines for the screening and investigation of liver functioning and Hepatitis B tests, implementing closer monitoring of patients.

Published on: 27 September, 2024

In December 1979, the Haemophilia Working Party met and discussed the fact that up to 70% of patients with severe haemophilia had abnormal liver function tests, with a wide spectrum of histological abnormalities.

Published on: 27 September, 2024

In 1970, at the haemophilia centre at Leeds, based at St James's University Hospital Dr Layinka Swinburne was the director and in 1985, she was joined by Dr Bernard McVerry.

Published on: 27 September, 2024

By 1977 the haemophilia centre at Leeds, based at St James's University Hospital were using a substantial amount of commercial concentrates.

Published on: 27 September, 2024

The haemophilia centre at Leeds, based at St James's University Hospital showed no evidence of batch dedication or evidence of risk reduction.

Published on: 27 September, 2024

In 1978 at the haemophilia centre at Leeds, based at St James's University Hospital very little cryoprecipitate was in use.

Published on: 27 September, 2024

In 1979 at the haemophilia centre at Leeds, based at St James's University Hospital there was no cryoprecipitate was in use.

Published on: 27 September, 2024

The haemophilia centre at Leeds, based at St James's University Hospital showed that by 1977, was using a substantial volume of commercial concentrate.

Published on: 27 September, 2024

Dr Bevan described how, in 1978, there was a limited amount of risk management that took place during that period.

Published on: 27 September, 2024

Commenting on the reaction to AIDS and the risk of transmission, Dr Bevan held that during the period around 1983, that the general attitude of doctors was not to alarm the public as there was no conclusive proof.

Published on: 27 September, 2024

During March 1983, a meeting was held, by the Haemostasis Club, where clinicians met to discuss and hold presentations that were topical to the medical field.

Published on: 27 September, 2024

Dr Bevan held the opinion that he did not understand why both UKHCDO and the reference centre directors were so slow to recognise and react to the risks of AIDS being transmitted to their patients and how he felt that it was a denial of the reality.

Published on: 27 September, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2324
  • Page 2325
  • Page 2326
  • Page 2327
  • Current page 2328
  • Page 2329
  • Page 2330
  • Page 2331
  • Page 2332
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.